Business Description
Venmax Drugs & Pharmaceuticals Ltd
ISIN : INE154G01022
Total Employee Number:
2Compare
Compare
Traded in other countries / regions
531015.India IPO Date
1995-08-21Description
Venmax Drugs & Pharmaceuticals Ltd is engaged in the manufacturing and sale of bulk drugs. The company is engaged in the business of IT & ITES services.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 25.91 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 1.41 | |||||
Interest Coverage | 100.29 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 5.62 | |||||
Beneish M-Score | 7.16 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -10.5 | |||||
3-Year EPS without NRI Growth Rate | -21.3 | |||||
3-Year FCF Growth Rate | -1177.9 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 66.39 | |||||
9-Day RSI | 54.5 | |||||
14-Day RSI | 48.82 | |||||
3-1 Month Momentum % | -29.62 | |||||
6-1 Month Momentum % | -26.87 | |||||
12-1 Month Momentum % | -33.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.95 | |||||
Quick Ratio | 7.46 | |||||
Cash Ratio | 4.22 | |||||
Days Inventory | 42.57 | |||||
Days Sales Outstanding | 122.36 | |||||
Days Payable | 126.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -18.8 | |||||
Shareholder Yield % | -77.73 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 9.27 | |||||
Operating Margin % | 0.88 | |||||
Net Margin % | 2.51 | |||||
EBITDA Margin % | 2.92 | |||||
FCF Margin % | -137.02 | |||||
OCF Margin % | -137.02 | |||||
ROE % | 2.46 | |||||
ROA % | 1.63 | |||||
ROIC % | 1.09 | |||||
3-Year ROIIC % | 5.43 | |||||
ROC (Joel Greenblatt) % | 7.64 | |||||
ROCE % | 2.81 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 47.58 | |||||
PE Ratio without NRI | 47.58 | |||||
PS Ratio | 1.63 | |||||
PB Ratio | 1.11 | |||||
Price-to-Tangible-Book | 1.11 | |||||
EV-to-EBIT | 32.41 | |||||
EV-to-EBITDA | 31.84 | |||||
EV-to-Revenue | 0.94 | |||||
EV-to-FCF | -0.52 | |||||
Price-to-Graham-Number | 1.53 | |||||
| Price-to-Net-Current-Asset-Value | 1.12 | |||||
| Price-to-Net-Cash | 2.42 | |||||
Earnings Yield (Greenblatt) % | 3.08 | |||||
FCF Yield % | -69.97 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Venmax Drugs & Pharmaceuticals Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 80.25 | ||
| EPS (TTM) (₹) | 0.376 | ||
| Beta | -0.9972 | ||
| 3-Year Sharpe Ratio | 0.6 | ||
| 3-Year Sortino Ratio | 3.51 | ||
| Volatility % | 62.89 | ||
| 14-Day RSI | 48.82 | ||
| 14-Day ATR (₹) | 2.13369 | ||
| 20-Day SMA (₹) | 17.6395 | ||
| 12-1 Month Momentum % | -33.6 | ||
| 52-Week Range (₹) | 15.56 - 36.96 | ||
| Shares Outstanding (Mil) | 8.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Venmax Drugs & Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Venmax Drugs & Pharmaceuticals Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Venmax Drugs & Pharmaceuticals Ltd Frequently Asked Questions
What is Venmax Drugs & Pharmaceuticals Ltd(BOM:531015)'s stock price today?
The current price of BOM:531015 is ₹17.89. The 52 week high of BOM:531015 is ₹36.96 and 52 week low is ₹15.56.
When is next earnings date of Venmax Drugs & Pharmaceuticals Ltd(BOM:531015)?
The next earnings date of Venmax Drugs & Pharmaceuticals Ltd(BOM:531015) is .
Does Venmax Drugs & Pharmaceuticals Ltd(BOM:531015) pay dividends? If so, how much?
Venmax Drugs & Pharmaceuticals Ltd(BOM:531015) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Venmax Drugs & Pharmaceuticals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers